Osteoporos Int 15:767–778PubMedCrossRef 23. Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, Johnell O (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12:519–528PubMedCrossRef 24. Cadarette SM, Jaglal SB, Kreiger N, McIsaac WJ, Darlington GA, Tu JV (2000) Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ 162:1289–1294PubMed 25. Robbins
J, Aragaki AK, Kooperberg C, Watts N, Wactawski-Wende J, Jackson RD, LeBoff MS, Lewis CE, Chen Z, Stefanick ML, Cauley J (2007) Factors associated with 5-year risk of hip fracture in postmenopausal HDAC inhibitor women. JAMA 298:2389–2398PubMedCrossRef 26. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability C188-9 manufacturer in men and women from the UK. Osteoporos Int 19:385–397PubMedCrossRef 27. Drummond M, O’Brien B, Stoddart G, Torrance
G (1997) Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford 28. Gold M, Siegel J, Russell L, Weinstein M (1996) Cost-effectiveness in health and medicine. Oxford University Press, New York 29. National Institute for Health and Clinical Excellence (2004) Guide to the methods of technology appraisal review process and timelines. http://www.nice.org.uk/niceMedia/pdf/GuideToTAMethodsReview.pdf 30. Borgstrom F, Jonsson B, Strom O, Kanis JA (2006) An economic evaluation of strontium ranelate in the Urocanase treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials. Osteoporos Int 17:1781–1793PubMedCrossRef 31. Hundrup YA, Hoidrup S, Obel EB, Rasmussen NK (2004) The validity of self-reported fractures among Danish female nurses: comparison
with fractures registered in the Danish National Hospital Register. Scand J Public Health 32:136–143PubMedCrossRef 32. Curtis JR, Westfall AO, Allison J, Freeman A, Kovac SH, Saag KG (2006) Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Pharmacoepidemiol Drug Saf 15:710–718PubMedCrossRef 33. Nevitt MC, Cummings SR, Browner WS, Seeley DG, Cauley JA, Vogt TM, Black DM (1992) The accuracy of self-report of fractures in elderly women: evidence from a prospective study. Am J Epidemiol 135:490–499PubMed 34. Chen Z, Kooperberg C, Pettinger MB, Bassford T, Cauley JA, LaCroix AZ, Lewis CE, Kipersztok S, Borne C, Jackson RD (2004) Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women’s Health Initiative observational study and clinical trials. Menopause 11:264–274PubMedCrossRef 35.